Samsung Bioepis, a subsidiary of Samsung Epice Holdings, announced on the 24th that its operating profit for the second quarter of this year was recorded at 86.6 billion won, a 3.6% decrease compared to the same period last year. Revenue for the same period fell 2.2% year-on-year to 392.2 billion won. The company explained that changes in the supply schedules of key products and increased investment in research and development (R&D) were the rea…